GlassScriptPhysician profile
Jaweed Sayeed
NPI 1194772780
$5,819.71
in general payments reported to CMS, 2019-2025
40 companies · $900 in 2025
The $900 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $695 · 2020: $85.02 · 2021: $818 · 2022: $1,266 · 2023: $1,015 · 2024: $1,041 · 2025: $900.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,956.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,956.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,058.64 | 2021-2025 | Corevalve Evolut R, Venaseal, Azure Xt Dr Mri Surescan |
| Boston Scientific Corporation | $680.95 | 2019-2025 | Avvigo Guidance System, General - Vascular Intervention, Varithena Administration Pack |
| Abiomed | $620.12 | 2019-2025 | |
| Abbott Laboratories | $594.20 | 2019-2024 | Thoratec Heartmate 3 Lvas Implant Kit, Diamondback Peripheral, Xience Skypoint |
| Amgen INC. | $342.42 | 2021-2025 | Repatha, Repatha |
| Janssen Pharmaceuticals, INC | $310.56 | 2021-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $260.28 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $242.03 | 2021-2025 | Verquvo |
| Silk Road Medical, INC. | $174.89 | 2023 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $167.45 | 2020-2024 | Lifevest |
| Acist Medical Systems, INC. | $130.59 | 2022-2025 | |
| Novo Nordisk INC | $121.98 | 2022-2025 | Ozempic |
| Astrazeneca Pharmaceuticals LP | $114.92 | 2020-2024 | Farxiga |
| Cardiovascular Systems INC. | $103.62 | 2019 | |
| Inari Medical, INC. | $82.67 | 2023-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $82.19 | 2022 | |
| Impulse Dynamics (USA) INC. | $70.16 | 2022-2023 | Optimizer |
| Actelion Pharmaceuticals US, INC. | $53.61 | 2024 | Opsumit, Uptravi |
| E.R. Squibb & Sons, L.L.C. | $47.60 | 2024 | Eliquis |
| Philips North America LLC | $46.37 | 2021-2024 | (P84) Igt Devices Systems |
| Medtronic Vascular, INC. | $45.72 | 2019 | |
| Atricure, INC. | $43.02 | 2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Cvrx, INC. | $38.51 | 2022-2023 | Barostim Neo System |
| Scpharmaceuticals INC. | $34.20 | 2023-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $32.69 | 2023-2024 | Jardiance |
| Biotronik INC. | $32.65 | 2021 | |
| Surmodics, INC. | $31.33 | 2022 | |
| Amarin Pharma, INC. | $30.18 | 2021 | |
| Cardiva Medical, INC. | $28.00 | 2020 | |
| Shockwave Medical, INC | $24.50 | 2022 | |
| Siemens Medical Solutions USA, INC. | $21.96 | 2022 | |
| Glaxosmithkline, LLC. | $21.82 | 2025 | Arexvy, Shingrix |
| Bayer Healthcare Pharmaceuticals INC. | $21.65 | 2025 | |
| Angiodynamics, INC. | $20.88 | 2023 | Auryon Laser System 100-120 Vac |
| Abbvie INC. | $20.37 | 2021 | |
| Inspire Medical Systems, INC. | $19.30 | 2025 | Inspire |
| Cashflow Solutions, LLC | $15.32 | 2024 | Pcd-51 731a (US) - White, Pcd-52 737a (US) White, Lympha Press Optimal Plus(US) Bt |
| Kiniksa Pharmaceuticals International, Plc | $13.15 | 2024 | Arcalyst |
| Chiesi USA, INC. | $12.71 | 2021 | |
| Thrombolex, INC. | $6.50 | 2024 | Bashir Endovascular Catheter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jaweed Sayeed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
The CSV has this whole record: totals, yearly figures, every listed company, payment types, and product associations.
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.